Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human

Drug Metabolism and Disposition

Volumn 37, Issue 1, 2009, Pages 66-73

  Li, Na ^a   Zhang, Yiqun ^a   Hua, Fengmei ^a   Lai, Yurong ^a,b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIVER CELL; MALE; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANIMALS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; DOGS; FEMALE; HEPATOCYTES; HUMANS; INFANT; LIVER; MACACA FASCICULARIS; MACACA MULATTA; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; TANDEM MASS SPECTROMETRY;

CANIS FAMILIARIS; RATTUS;

EID: 58149465922     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.023234     Document Type: Article

References (42)

1. Arias IM, Che M, Gatmaitan Z, Leveille C, Nishida T, and St Pierre M (1993) The biology of the bile canaliculus, 1993. Hepatology 17:318-329.
2. Ayrton A and Morgan P (2001) Role of transport proteins in drug absoiption, distribution and excretion. Xenobiotica 31:469-497.
3. Barnidge DR, Dratz EA, Martin T, Bonilla LE, Moran LB, and Lindall A (2003) Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal Chem 75:445-451.
4. Barnidge DR, Goodmanson MK, Klee GG, and Muddiman DC (2004) Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry. J Proteome Res 3:644-652.
5. Behrens I, Kamm W, Dantzig AH, and Kissel T (2004) Variation of peptide transporter (PepTl and HPTl) expression in Caco-2 cells as a function of cell origin. J Phami Sci 93:1743-1754.
6. Bow DA, Perry JL, Miller DS, Pritchard JB, and Brouwer KL (2008) Localization of P-gp (Abcbl) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes. Drug Metab Dispos 36:198-202.
7. Buchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T, and Keppler D (1996) cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Bio Chem 271:15091-15098.
8. Courtois A, Pay en L, Le Ferrec E, Scheffer GL, Trinquart Y, Guillouzo A, and Fardel O (2002) Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2Bl/2and 3A1/2 in phenobarbital-treated hepatocytes. Biochem Pharmacol 63:333-341.
9. Dedrick R, Bischoff KB, and Zaharko DS (1970) Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chem other Rep 54:95-101.
10. Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, Meijer DK, and Groothuis GM (2004) LPS-induced down regulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287:G1008-G1016.
11. Fromm MF, Kauffmann HM, Fritz P, Burk O, Kroemer HK, Warzok RW, Eichelbaum M, Siegmund W, and Schrenk D (2000) The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pafhol 157:1575-1580.
12. Goh LB, Spears KJ, Yao D, Ayrton A, Morgan P, Roland Wolf C, and Friedberg T (2002) Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. Biochem Pharmacol 64:1569-1578.
13. Hartmann G, Cheung AK, and Piquette-Miller M (2002) Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther 303:273-281.
14. Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell AL, and Karlsson J (2007) Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35:1333-1340.
15. Ishizuka H, Konno K, Shiina T, Naganuma H, Nishimura K, Ito K, Suzuki H, and Sugiyama Y (1999) Species differences in the transport activity for organic anions across the bile canalicular membrane. J Pharmacol Exp Ther 290:1324-1330.
16. Ito K, Iwatsubo T, Kanamitsu S, Nakajima Y, and Sugiyama Y (1998) Quantitative prediction of in vivo ding clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annu Rev Pharmacol Toxicol 38:461-499.
17. Iwatsubo T, Hirota N, Ooie T, Suzuki H, Shimada N, Chiba K, Ishizaki T, Green CE, Tyson CA, and Sugiyama Y (1997) Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol Ther 73:147-171.
18. John H, Walden M, Schafer S, Genz S, and Forssmann WG (2004) Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry. Anal Bioanal Chem 378:883-897.
19. Jones BR, Li W, Cao J, Hoffman TA, Gerk PM, and Vore M (2005) The role of protein synthesis and degradation in the post-transcriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2). Mol Pharmacol 68:701-710.
20. Keppler D and Arias IM (1997) Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane. FASEB J 11:15-18.
21. 13C-labeled peptide standards. Proteomics 4:1175-1186.
22. Lam XL and Benet LZ (2004) Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes. Drug Metab Dispos 32:1311-1316.
23. Lave T, Portmann R, Schenker G, Gianni A, Guenzi A, Girometta MA, and Schmitt M (1999) Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor. J Pharm Pharmacol 51:85-91.
24. Li M, Yuan H, Li N, Song G, Zheng Y, Baratta M, Hua F, Thurston A, Wang J, and Lai Y (2008a) Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. Eur J Pharm Set 35:114-126.
25. Li N, Nemirovskiy OV, Zhang Y, Yuan H, Mo J, Ji C, Zhang B, Brayman TG, Lepsy C, Heath TG, et al. (2008b) Absolute quantification of multidrug resistance-associate protein 2 (MRP2/ABCC2) Using LC-MS/MS. Anal Biochem 380:211-222.
26. Mahmood I (1999) Allometric issues in drug development. J Pharm Sci 88:1101-1106.
27. Mahmood I and Sahaj walla C (2002) Interspecies scaling of biliary excreted drugs. J Pharrn Sci 91:1908-1914.
28. Meyer zu Schwabedissen HE, Jedlitschky G, Gratz M, Haenisch S, Linnemann K, Fusch C, Cascorbi I, and Kroemer HK (2005) Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab Dispos 33: 896-904.
29. Muller M and Jansen PL (1997) Molecular aspects of hepatobiliarv transport. Am J Phvsiol 272:G1285-G1303.
30. Niinuma K, Takenaka O, Horie T, Kobayashi K, Kato Y, Suzuki H, and Sugiyama Y (1997) Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of, S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamiuo-4-(3- pyridylmethyl)benzothiazole glucuronide. J Pharmacol Exp Ther 282:866-872.
31. Ninomiya M, Ito K, Hiramatsu R, and Horie T (2006) Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2). Drug Metab Dispos 34:2056-2063.
32. Ninomiya M, Ito K, and Horie T (2005) Functional analysis of dog multidrug resistanceassociated protein 2 (Mrp2) in comparison with rat Mrp2. Drug Metab Dispos 33:225-232.
33. Oude Elferink RP, Ottenhoff R, Liefting WG, Schoemaker B, Groen AK, and Jansen PL (1990) ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatoevtes. Am J Phvsiol 258:G699-G706.
34. Pahlmau I, Wileu M, and Bowald S (1999) Efficient biliary excretion of susalimod, probably via the bromosulphthalein earner, studied in a chronic bile fistula model in dogs. J Pharm Pharmacol 51:61-66.
35. Shilling AD, Azam F, Kao J, and Leung L (2006) Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane. J Pharmacol Toxicol Methods 53:186-197.
36. Shitara Y, Sato H, and Sugiyama Y (2005) Evaluation of drug-drug interaction in the hepatobiliarv and renal transport of drugs. Annu Rev Pharmacol Toxicol 45:689-723.
37. Suzuki H and Sugiyama Y (1999) Transporters for bile acids and organic anious. Pharm Biotechnol 12:387-439.
38. Taipaleusuu J, Taveliu S, Lazorova L, Sveussou AC, and Artursson P (2004) Exploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker of MDR1 -dependent drug efflux activity. Eur J Pharm Sci 21:69-75.
39. Takekuma Y, Kalduchi H, Yamazaki K, Miyauchi S, Kikukawa T, Kamo N, Ganapathy V, and Sugawara M (2007) Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form. J Pharm Pharm Sci 10:71-85.
40. Wu SL, Amato H, Biringer R, Choudhary G, Shieh P, and Hancock WS (2002) Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system. J Proteome Res 1:459-465.
41. Zhang Y, Li W, and Vore M (2007) Translational regulation of rat multidrug resistanceassociated protein 2 expression is mediated by upstream open reading frames in the 5′ untranslated region. Mol Pharmacol 71:377-383.
42. Zinchuk VS, Okada T, Akimaru K, and Seguchi H (2002) Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. Am J Phvsiol Gasfrointest Liver Phvsiol 282:G540-G548.